Correction

2007 Circulation  
several changes are needed. After online publication of these guidelines, the writing group was made aware that there was confusion among the readership regarding the use of the language "Recommended" in the title of Tables 3 and 4 and "may be reasonable" or "may be considered" in the text when referring to our Class IIb recommendations. The writing group has clarified this by revising the wording in the tables and changing the language in the text to "is reasonable." According to existing
more » ... can Heart Association policy for wording of classes of recommendations, this change in language is accompanied by a shift in the class of recommendation from IIb to IIa as detailed in the errata. 1. Since the online publication of this article, the American Academy of Pediatrics and the International Society of Chemotherapy for Infection and Cancer* have added their endorsements. 2. On page 1736, in the footnotes section, the following footnote applies to the endorsement by the International Society of Chemotherapy for Infection and Cancer: "*If these guidelines are applied outside of the United States of America, adaptation of the recommended antibiotic agents may be considered with respect to the regional situation." 3. On page 1737, in the Conclusions part of the abstract, the following items have been modified: "(2) Infective endocarditis prophylaxis for dental procedures is reasonable only for patients with underlying cardiac conditions associated with the highest risk of adverse outcome from infective endocarditis. (3) For patients with these underlying cardiac conditions, prophylaxis is reasonable for all dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa." 4. In Table 3 on page 1745, the following items have been modified: a. The title now reads: "Cardiac Conditions Associated With the Highest Risk of Adverse Outcome From Endocarditis for Which Prophylaxis With Dental Procedures Is Reasonable" b. The first entry now reads: "Prosthetic cardiac valve or prosthetic material used for cardiac valve repair" c. The second footnote now reads: " †Prophylaxis is reasonable because endothelialization of prosthetic material occurs within 6 months after the procedure." 5. On page 1745, second column, second paragraph, the fifth sentence has been modified to read: "As shown in Table 3 , the Committee concludes that prophylaxis is reasonable for dental procedures for these patients during the first 6 months after the procedure." 6. On page 1745, second column, third paragraph, the last sentence has been modified to read: "In patients with underlying cardiac conditions associated with the highest risk of adverse outcome from IE (Table 3 ), IE prophylaxis for dental procedures is reasonable, even though we acknowledge that its effectiveness is unknown (Class IIa, LOE B). 7. On page 1746, first column, first full paragraph, the third sentence has been modified to read: "Additionally, the change in emphasis to restrict prophylaxis for only those patients with the highest risk of adverse outcome should reduce the uncertainties among patients and providers about who should receive. . .." 8. On page 1746, first column, the section heading has been modified from "Regimens Recommended" to "Antibiotic Regimens."
doi:10.1161/circulationaha.107.185599 fatcat:jeysq4vxpjhehhivzlciybqcyu